logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
G

Gynecologic Oncology

IF4.1
论文数303
被引数
期刊论文 303
发表时间
delete
The Duffy-Null genotype and epithelial ovarian cancer survival in a cohort of Black womenDuffy-Null基因型与黑人女性上皮性卵巢癌预后的关系
deleteGynecologic Oncology
IF4.1
delete2026-10-28
delete0
deleteOAAI
deleteJoellen M. Schildkraut; Jeffrey R. Marks; Lauren C. Peres; Xintian Song; Anthony J. Alberg; Katherine A. Lawson-Michod; Courtney E. Johnson; Lindsay J. Collin; Jennifer A. Doherty; Elisa V. Bandera; Melissa L. Bondy; Theresa A. Hastert; Michele L. Coté; Edward S. Peters; Kristin Haller; Paul D. Terry; Michael P. Epstein; Yao Xin; Andrew B. Lawson
delete分享
delete收藏
Heterogeneity of folate receptor alpha expression and associations with molecular biomarker in ovarian high-grade serous carcinoma: A multicenter Chinese cohort study叶酸受体α表达异质性及其与分子生物标志物的关联：一项多中心中国队列研究
deleteGynecologic Oncology
IF4.1
delete2026-10-27
delete0
PREAI
deleteFeifei Li; Danhui Li; Yun Xi; Wei Wang; Yang Yang; Lijuan Bian; Shenglei Li; Junqiu Yue; Wenfeng Cao; Jing Zhang; Yan Song; Xuyong Lin; Zhiyong Liang; Xiaohua Shi; Rui Bi; He Jiang; Dengfeng Cao; Aijun Liu
delete分享
delete收藏
LMOD1 expression and survival in uterine leiomyosarcoma: discordant results in tissue microarrays and whole sectionsLMOD1表达与子宫平滑肌肉瘤的生存：组织微阵列和全切片结果不一致
deleteGynecologic Oncology
IF4.1
delete2026-10-27
delete0
deleteOAAI
deleteBen Davidson; Arild Holth; Guro Horni Gløersen
delete分享
delete收藏
Trends in utilization of cervical cancer screening and screening-associated services in a multi-organizational research network in Chicago, Illinois, US美国伊利诺伊州芝加哥市多机构研究网络中宫颈癌筛查及相关服务的利用趋势
deleteGynecologic Oncology
IF4.1
delete2026-10-26
delete0
deleteOAAI
deleteHunter K. Holt; Weiwei Ma; Howard S. Gordon; Jiehuan Sun; Stacie Geller; Sarah Lomahan; Dana Bright; Helen Cejtin; Jasmin A. Tiro; Caryn E. Peterson
delete分享
delete收藏
A cross-sectional survey exploring experiences in accessing hormone replacement therapy following risk-reducing surgery for individuals with hereditary ovarian cancer risk一项关于遗传性卵巢癌风险个体在接受风险降低手术后的激素替代疗法获取经历横断面调查
deleteGynecologic Oncology
IF4.1
delete2026-10-23
delete0
deleteOAAI
deleteShelby Thornton; Melanie O'Loughlin; Jennifer Nuk; Kennedy Borle; Lesa Dawson; Courtney B. Cook
delete分享
delete收藏
Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL)CABOCOL研究中卡博替尼治疗复发或转移性宫颈癌的II期研究（在铂类化疗进展后）
deleteGynecologic Oncology
IF4.1
delete2026-10-23
delete0
PREAI
deleteElodie Coquan; Roman Vion; Emeline Colomba-Blamemble; Jean-Sébastien Frenel; Cyril Abdeddaim; Véronique D'Hondt; Sophie Abadie-Lacourtoisie; Coraline Dubot; Pierre-Emmanuel Brachet; Marie Castera; Alexandra Leconte; Ludivine Beaussire-Trouvay; Florian Clatot; Florence Joly; Justine Lequesne; Bénédicte Clarisse
delete分享
delete收藏
Incidence and clinical impact of venous thromboembolism during immunotherapy for gynecologic cancer妇科癌症免疫治疗期间静脉血栓栓塞的发病率和临床影响
deleteGynecologic Oncology
IF4.1
delete2026-10-22
delete0
PREAI
deleteCassidy S. Abdeen; Jessica Sciuva; Reed M. O'Connor; Jessica Fulton; Julia Chalif; Danielle C. Glassman; Anna Gonzalez; Molly A. Morton; Jessica Velasquez; David E. Cohn; Larry J. Copeland; Casey M. Cosgrove; Paulina J. Haight; Christa I. Nagel; Robert Neff; Floor J. Backes; David M. O'Malley; Laura M. Chambers
delete分享
delete收藏
Corrigendum to “Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumors” [Gynecol. Oncol. 197 (2025) 139–145]勘误：“全外显子组测序为评估同源重组缺陷以识别对PARPi敏感的卵巢肿瘤” [Gynecol. Oncol. 197 (2025) 139–145]
deleteGynecologic Oncology
IF4.1
delete2026-10-21
delete0
PREAI
deleteElizabeth Evans; Jhalak Dholakia; Jim Abraham; Andrew Hinton; Jian Zhang; Joanne Xiu; Todd Maney; Matt Oberley; Premal Thaker; Thomas Herzog; David Spetzler; Rebecca C. Arend
delete分享
delete收藏
How slow should we go? Variation and outcomes of steroid tapering for immunotherapy-related toxicities in gynecologic cancer我们应该放慢多少速度？妇科肿瘤免疫治疗相关毒性的糖皮质激素减量变化及结局
deleteGynecologic Oncology
IF4.1
delete2026-10-20
delete0
deleteOAAI
deleteJessica Velasquez; Julia Chalif; Danielle Glassman; Anna Gonzalez; Reed O'Connor; Cassidy Abdeen; Floor J. Backes; David E. Cohn; Larry J. Copeland; Casey M. Cosgrove; Paulina J. Haight; Christa I. Nagel; Robert Neff; David M. O'Malley; Laura M. Chambers
delete分享
delete收藏
Implementation and sustainability of surgical randomized trials in gynecologic oncology: Adoption beyond publication妇科肿瘤外科随机试验的实施与可持续性：出版后的应用推广
deleteGynecologic Oncology
IF4.1
delete2026-10-20
delete0
PREAI
deleteNuria Agusti; Alexandra Bercow; Pedro T. Ramirez; Marie Plante; Anne Knisely; Philipp Harter; Anna Fagotti; Andreas Obermair; J. Alejandro Rauh-Hain
delete分享
delete收藏
Trends in immunotherapy utilization among older adults with advanced endometrial cancer: An NCDB analysis老年晚期子宫内膜癌患者免疫疗法使用趋势：NCDB分析
deleteGynecologic Oncology
IF4.1
delete2026-10-17
delete0
PREAI
deleteNicha Assavapokee; Caroline Gellman; Stephanie V. Blank; Caitlin Carr
delete分享
delete收藏
Genomic characterization of advanced and recurrent endometrial carcinoma: KRAS and TP53 co-mutation as a biomarker for adverse prognosis and therapeutic failure高级别和复发性子宫内膜癌的基因组特征：KRAS和TP53共突变作为不良预后和治疗效果不佳的生物标志物
deleteGynecologic Oncology
IF4.1
delete2026-10-16
delete0
PREAI
deleteSanghoo Lee; Kyeong-A So; Soyeon Kim; Mi-Kyeong Lee; Yun Hwan Kim; Tae Jin Kim; Mi-Kyung Kim
delete分享
delete收藏
Impact of adjuvant treatment on survival in surgically staged 2009 FIGO stage I uterine serous carcinoma2009 FIGO分期I期子宫浆液性癌手术分期术后辅助治疗对生存的影响
deleteGynecologic Oncology
IF4.1
delete2026-10-15
delete0
PREAI
deleteStephen M. Graves; Katherine Yoh; Tiffany Y. Sia; Vicky Makker; Roisin E. O'Cearbhaill; Ying L. Liu; Kaled Alektiar; Jennifer J. Mueller; Vance Broach; Sarah H. Kim; Evan Smith; Jacqueline Feinberg; Lora H. Ellenson; Nadeem R. Abu-Rustum; Mario M. Leitao
delete分享
delete收藏
Immunoaffinity-enriched extracellular vesicle proteomics for high-grade serous ovarian cancer - A UKOPS nested case-control analysis免疫亲和富集的细胞外囊泡蛋白质组学在高级别浆液性卵巢癌中的应用——一项UKOPS巢式病例对照分析
deleteGynecologic Oncology
IF4.1
delete2026-10-15
delete0
PREAI
deleteCarlos Salomon; Andrew Lai; Dominic Guanzon; Katherin Scholz-Romero; Nihar Godbole; Carlos Palma; Sophia Apostolidou; Aleksandra Gentry-Maharaj; Gregory E. Rice; Usha Menon
delete分享
delete收藏
A second chance? Outcomes of immunotherapy retreatment after prior checkpoint inhibitor exposure in endometrial and cervical cancer子宫内膜癌和宫颈癌中，在先前接受过免疫检查点抑制剂治疗后进行免疫疗法再治疗的结局如何？
deleteGynecologic Oncology
IF4.1
delete2026-10-14
delete0
deleteOAAI
deleteJulia Chalif; Molly Morton; Reed O'Connor; Anna Gonzalez; Aidan Coon; Cassidy Abdeen; David E. Cohn; Casey M. Cosgrove; Larry J. Copeland; Christa I. Nagel; Floor Backes; David M. O'Malley; Laura M. Chambers
delete分享
delete收藏
Real-world outcomes of first-line pembrolizumab monotherapy among dMMR/MSI-H advanced or recurrent endometrial cancer patients in the United States美国dMMR/MSI-H晚期或复发性子宫内膜癌患者一线帕博利珠单抗单药治疗的真实世界结局
deleteGynecologic Oncology
IF4.1
delete2026-10-10
delete0
deleteOAAI
deleteKathleen M. McClain; Vimalanand S. Prabhu; Srujitha Marupuru; Ke Meng; Vy Tran; Robert Orlowski; Robin Meng; Angela K. Green; Vicky Makker
delete分享
delete收藏
Platinum resistant ovarian cancer - No longer a graveyard for drug development铂耐药性卵巢癌——不再是药物开发的坟墓
deleteGynecologic Oncology
IF4.1
delete2026-10-09
delete0
PREAI
deleteKrishnansu S. Tewari
delete分享
delete收藏
Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort子宫内膜癌多样化社区队列中致病性生殖细胞变异的流行率及检测指征
deleteGynecologic Oncology
IF4.1
delete2026-10-01
delete0
PREAI
deleteElizabeth Suh-Burgmann; Holly Finertie; Yun-Yi Hung; Elizabeth Hoodfar; Holly Carwana; Haoyuan Zhong; Claudia Nau; Julie Schmittdiel
delete分享
delete收藏
Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer在重度预处理的铂耐药卵巢癌中，帕博利珠单抗联合贝伐珠单抗和口服定期环磷酰胺的实时临床疗效
deleteGynecologic Oncology
IF4.1
delete2026-10-01
delete0
PREAI
deleteGabriella Smith; Aaron Petty; Kevin Krivanek; Peter G. Rose
delete分享
delete收藏
The diagnostic value of serum glucagon-like peptide-1 (GLP-1) levels in endometrial cancer among obese women肥胖女性子宫内膜癌中血清胰高血糖素样肽-1（GLP-1）水平的诊断价值
deleteGynecologic Oncology
IF4.1
delete2026-09-28
delete0
PREAI
deleteArzu Bostancı Durmuş; Gamze Sinem Yücel
delete分享
delete收藏